EXACT Cost Of Revenue from 2010 to 2024

EXAS Stock  USD 63.16  1.58  2.57%   
EXACT Sciences Cost Of Revenue yearly trend continues to be comparatively stable with very little volatility. Cost Of Revenue is likely to outpace its year average in 2024. From the period from 2010 to 2024, EXACT Sciences Cost Of Revenue quarterly data regression had mean square error of 12119.8 T and mean deviation of  216,201,909. View All Fundamentals
 
Cost Of Revenue  
First Reported
2000-03-31
Previous Quarter
213.2 M
Current Value
196.1 M
Quarterly Volatility
55.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT Sciences' main balance sheet or income statement drivers, such as Interest Expense of 25.6 M, Other Operating Expenses of 2.9 B or Research Development of 447.2 M, as well as many indicators such as Price To Sales Ratio of 5.06, Dividend Yield of 0.0 or PTB Ratio of 4.47. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.
  
Check out the analysis of EXACT Sciences Correlation against competitors.
For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

Latest EXACT Sciences' Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of EXACT Sciences over the last few years. Cost of Revenue is found on EXACT Sciences income statement and represents the costs associated with goods and services EXACT Sciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is EXACT Sciences' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EXACT Sciences' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

EXACT Cost Of Revenue Regression Statistics

Arithmetic Mean221,433,817
Coefficient Of Variation114.87
Mean Deviation216,201,909
Median79,196,000
Standard Deviation254,358,499
Sample Variance64698.2T
Range687.4M
R-Value0.91
Mean Square Error12119.8T
R-Squared0.83
Slope51,693,417
Total Sum of Squares905775.4T

EXACT Cost Of Revenue History

2024687 M
2023654.2 M
2022574.4 M
2021458.8 M
2020354.3 M
2019216.7 M
2018118 M

About EXACT Sciences Financial Statements

EXACT Sciences shareholders use historical fundamental indicators, such as Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although EXACT Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in EXACT Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on EXACT Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue654.2 M687 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for EXACT Stock Analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.